Rare Disease Day is a global awareness campaign held on the last day of February each year, designed to draw attention to the roughly 300 million people worldwide living with a rare disease. Created by EURORDIS (Rare Diseases Europe) in 2008, it has grown into one of the largest patient-led advocacy events in the world, with participation from organizations, hospitals, governments, and families across dozens of countries.
Why the Last Day of February
February was chosen because it is itself the “rarest” month, the only one without 30 or 31 days. In most years, Rare Disease Day falls on February 28th. During leap years, it lands on February 29th, a date that comes around only once every four years, making it symbolically fitting for conditions that are themselves uncommon.
What Counts as a Rare Disease
The definition depends on where you live. In the United States, the 1983 Orphan Drug Act defines a rare disease as any condition affecting fewer than 200,000 people. In the European Union, the threshold is 5 or fewer people per 10,000. Either way, the numbers per condition are small, but the collective impact is enormous. Scientists have identified nearly 10,000 distinct rare diseases, and together they affect an estimated 300 million people globally.
Despite those numbers, only about 5 percent of known rare diseases have an approved treatment. That gap between the scale of the problem and the availability of therapies is one of the central issues Rare Disease Day seeks to highlight.
The Diagnostic Odyssey
One of the most common experiences shared on Rare Disease Day is the so-called “diagnostic odyssey,” the often years-long journey patients go through before anyone can tell them what’s wrong. Research published in the Orphanet Journal of Rare Diseases found that patients with suspected rare conditions consulted an average of 7.3 specialists before reaching a diagnosis, compared to about 4.3 for matched controls. On average, these patients reported nearly 7 years between the first appearance of symptoms and the start of specialized evaluation.
That delay isn’t just frustrating. It means years of incorrect treatments, unnecessary procedures, and emotional toll for patients and their families. Raising awareness of rare diseases among both the public and medical professionals is one way to shorten that timeline.
Who Organizes It
EURORDIS coordinates Rare Disease Day internationally, working through a network of national alliance partners, patient organizations, and individual advocates. In the United States, the National Organization for Rare Disorders (NORD) plays a prominent role, and the National Institutes of Health hosts its own annual Rare Disease Day event through the National Center for Advancing Translational Sciences. That event brings together researchers, patients, and caregivers to share the latest developments in diagnosis and treatment and to spotlight personal stories from the rare disease community.
How People Participate
One of the most visible traditions is the Global Chain of Lights, in which landmarks, bridges, and public buildings around the world are illuminated in the campaign’s official colors: pink, green, blue, and magenta. The goal is to make the “invisible” visible, turning physical spaces into symbols of solidarity with people whose conditions are often overlooked or misunderstood. In 2026, for example, Budapest’s Megyeri Bridge is among the landmarks scheduled to light up on the evening of February 28th.
Beyond the lights, participation takes many forms. Patient organizations hold educational events and fundraisers. Schools and workplaces organize awareness activities. Individuals share their stories on social media. Researchers present new findings. The common thread is turning a single day into a catalyst for year-round attention to rare diseases.
Policy Impact
Rare Disease Day has helped push rare diseases onto the agendas of major institutions. In December 2021, the United Nations General Assembly adopted its first resolution specifically addressing the challenges of people living with rare diseases, paving the way for greater integration of rare disease issues into UN priorities. The World Health Organization has since framed rare diseases as a global health priority tied to equity and inclusion, recognizing that many patients in lower-resource countries face even steeper barriers to diagnosis and care.
These policy milestones matter because they translate awareness into structural change: more funding for research, better coordination between health systems, and stronger incentives for developing treatments for conditions that each affect small numbers of people but collectively represent a significant share of human illness.